Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Novartis
Citi
McKinsey
US Department of Justice
Cerilliant
Boehringer Ingelheim
QuintilesIMS
Fuji
Accenture

Generated: October 22, 2017

DrugPatentWatch Database Preview

Drug Master Files for: fluoxetine

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
4673III10/15/1982LILLY RESEARCH LABORATORIES DIV ELI LILLY AND COFLUOXETINE HYDROCHLORIDE, BULK
8695AII8/7/1990OLON SPAFLUOXETINE HYDROCHLORIDE
10837AII3/28/1994ERREGIERRE SPAFLUOXETINE HYDROCHLORIDE USP-EP
11315AII1/26/1995FERMION OYFLUOXETINE HYDROCHLORIDE USP
11699III10/4/1995SIMS SRLFLUOXETINE HCL
11992III6/7/1996NATCO PHARMA LTDFLUOXETINE HYDROCHLORIDE
12009AII6/19/1996OLON SPAFLUOXETINE HYDROCHLORIDE
12146AII10/2/1996TEVA PHARMACEUTICAL INDUSTRIES LTDFLUOXETINE HCI
12221III11/15/1996CILAG AGFLUOXETINE HYDROCHORIDE
12291AII12/18/1996QUIMICA SINTETICA SAFLUOXETINE HYDROCHLORIDE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
UBS
Boehringer Ingelheim
Julphar
US Department of Justice
Mallinckrodt
McKinsey
AstraZeneca
Covington
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot